Pro Medicus (OTCMKTS:PMCUF) Shares Down 3.8%

Pro Medicus Limited (OTCMKTS:PMCUFGet Free Report)’s share price traded down 3.8% during trading on Friday . The stock traded as low as $45.12 and last traded at $45.12. 1,488 shares traded hands during mid-day trading, an increase of 114% from the average session volume of 695 shares. The stock had previously closed at $46.89.

Analyst Ratings Changes

Several equities analysts have commented on the company. The Goldman Sachs Group raised Pro Medicus from a “neutral” rating to a “buy” rating in a research report on Thursday, July 27th. Jefferies Financial Group initiated coverage on Pro Medicus in a research note on Thursday, June 29th. They set a “hold” rating for the company.

View Our Latest Stock Analysis on PMCUF

Pro Medicus Stock Performance

The business has a 50 day moving average of $45.31 and a two-hundred day moving average of $43.07.

About Pro Medicus

(Get Free Report)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and, an e-health platform.

Further Reading

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with's FREE daily email newsletter.